0001104659-23-069474 Sample Contracts

SW PARENTCO, INC. SECURED CONVERTIBLE NOTE PURCHASE AGREEMENT

Subordination Agreement • June 8th, 2023 • Lewis & Clark Ventures I, LP • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Subordination Agreement
• Filed
  June 8th, 2023
• Company
  Lewis & Clark Ventures I, LP
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Secured Convertible Note Purchase Agreement, dated as of May 29, 2023 (this “Agreement”), is entered into by and among SW ParentCo, Inc., a Delaware corporation (the “Company”), and the undersigned persons and entities (each an “Investor” and, collectively, the “Investors”).

AGREEMENT AND PLAN OF MERGER by and among SW PARENTCO, INC. SW MERGERCO, INC. and GreenLight Biosciences Holdings, PBC Dated as of May 29, 2023

Agreement and Plan of Merger • June 8th, 2023 • Lewis & Clark Ventures I, LP • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Agreement and Plan of Merger
• Filed
  June 8th, 2023
• Company
  Lewis & Clark Ventures I, LP
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Agreement and Plan of Merger (the “Agreement”), dated as of May 29, 2023, is by and among SW ParentCo, Inc., a Delaware corporation (“Parent”), SW MergerCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and GreenLight Biosciences Holdings, PBC, a Delaware public benefit corporation (the “Company”).

CONTRIBUTION AND EXCHANGE AGREEMENT

Voting Agreement • June 8th, 2023 • Lewis & Clark Ventures I, LP • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Voting Agreement
• Filed
  June 8th, 2023
• Company
  Lewis & Clark Ventures I, LP
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

Joint Filing Agreement

Joint Filing Agreement • June 8th, 2023 • Lewis & Clark Ventures I, LP • Biological products, (no disgnostic substances)

• Contract Type
  Joint Filing Agreement
• Filed
  June 8th, 2023
• Company
  Lewis & Clark Ventures I, LP
• Industry
  Biological products, (no disgnostic substances)

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of GreenLight Biosciences Holdings, PBC, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.